ONE hundred women were diagnosed with cervical cancer during the first year of CervicalCheck – the national cervical screening programme.

A WOMEN’S health clinic is concerned that a crucial high uptake of the cervical cancer vaccine may be difficult to maintain when it is rolled out nationwide in September.

THE National Cancer Screening Service (NCSS) has launched an investigation into why more than 40,000 letters to women entitled to a free smear test were returned unopened.

UP TO 30,000 schoolgirls will be vaccinated free of charge against cervical cancer later this year following a dramatic reversal of Government policy.

GLOBAL online payments company PayPal has announced the creation of 100 jobs at its European centre in Dublin.

NO extra funding will be made available for a national screening programme for the country’s second most deadly form of cancer, it has been confirmed.

A screening programme that will save hundreds of lives by diagnosing the early stages of bowel cancer should be rolled out across the country, experts said today.

The National Cancer Screening Service (NCSS) is recommending the roll-out of a national colorectal screening programme for men and women in Ireland.

THE roll-out of Breast- Check, the national breast screening programme, is under threat in counties Clare, Leitrim and Donegal because of a shortage of radiographers and a ban on recruitment.

WITH over 900 people dying of bowel cancer in Ireland every year, and over half of patients presenting with the disease at a late stage, the Irish Cancer Society has nominated April as Ireland’s first Bowel Cancer Awareness Month.

THE National Cancer Screening Service (NCSS) confirmed that it has signed an initial two-year contract with Quest Diagnostics in the US to provide laboratory testing services for the national cervical screening programme.

THE row over the Government’s decision to select a US company to process Ireland’s cervical smear tests deepened last night after a Fine Gael TD claimed cancer could go undetected in up to 2,000 women.

A ROW has broken out over the awarding of preferred bidder status for laboratory testing of cervical smears to a private US company.

ANY innovation that reduces the risk posed by cancer is welcome, most especially if it is long overdue.